Zepbound 7.5 MG/0.5 ML pen 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26FJJ7F
Awardee
Awarding agency
Obligated
$3,995

Award facts

Contract value 100% obligated
$3,994.94 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,994.94 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract was awarded on January 21, 2026, with an ultimate completion date of January 22, 2026, and represents a firm fixed-price procurement with no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company has demonstrated capability to meet federal requirements through open competition, with its federal contract portfolio spanning diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions, with AmerisourceBergen positioned as a key supplier alongside anticipated future multiple-award contracts under the emerging Pharmaceutical Prime Vendor Global Program Generation V initiative.

Quick answers

Who was awarded contract SPE2DR26FJJ7F?

SPE2DR26FJJ7F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.

How much is contract SPE2DR26FJJ7F worth?

The government has obligated $3,995 on SPE2DR26FJJ7F.

Is contract SPE2DR26FJJ7F an order under another contract?

Yes. SPE2DR26FJJ7F is a delivery order under SPE2DR25D1106, an indefinite delivery contract.

Was contract SPE2DR26FJJ7F competed?

The extent of competition for SPE2DR26FJJ7F was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award